Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer.
D004317:Doxorubicin / Q000008:administration & dosage* / Q000097:blood / Q000633:toxicity; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010538:Peritonitis / Q000139:chemically induced
D004317:Doxorubicin